Cognitive Bias Modification for Interpretation Individuals With Chronic Musculoskeletal Pain
CompletedNot applicableNCT06368362
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Cognitive Bias Modification for Interpretation (CBM-I) trains participants to interpret ambiguous information as neutral or benign, rather than interpret it as being related to pain. The goal of this randomised controlled trial was to explore the feasibility and potential clinical benefits of CBM-I in people with chronic pain and also healthy, pain-free individuals.
Study details
- Official title
- The Effectiveness and Mediators of Cognitive Bias Modification for Interpretation in the Reduction of Negative Emotional Response to Pain in Individuals With Chronic Musculoskeletal Pain
- Conditions
- Chronic Pain
- Musculoskeletal Pain Disorder
- Interventions
- Behavioral: Benign cognitive bias modification for interpretation
- Behavioral: Pain-related cognitive bias modification for interpretation
- Sponsor
- University of Southampton
- Collaborators
- Economic and Social Research Council, United Kingdom
- Start date
- 2020-11-17
- Primary completion
- 2021-05-01
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United Kingdom
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Chronic pain group Inclusion criteria * Experience musculoskeletal pain (pain in muscles, bones, joints, tendons, or ligaments) that has lasted for at least the last 3 months before enrolment in the study * Have visited a healthcare professional for their pain * Aged 18-70 years * Normal or corrected to normal vision * Fluency in the English language Exclusion criteria * Any known reading difficulty Healthy group Inclusion criteria * Aged 18-70 years * Normal or corrected to normal vision * Fluency in the English language Exclusion criteria * Experience frequent or continuous pain for the past three months before enrolment in the study * Currently experiencing pain * Any known reading difficulty
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06368362